Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P140: Challenges in colonoscopic surveillance in chronic IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

S-L. Gillespie*1, N. Singh-Clark2, A. Shand1, C. Lees1, I. Arnott1, G-T. Ho1, E. Watson1, C. Noble1, S. Din1

1Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK, 2University of Edinburgh, Edinburgh, UK

P141: Faecal calprotectin correlates to UCEIS and can predict short-term recurrence in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Naganuma*1, T. Kobayashi2, T. Kanai1

1Division of Gastroenterology and Hepatology, Keio University, Tokyo, Japan, 2Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan

P142: Ulcerative colitis: risk factors for relapse in clinical remission patients

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Arieira*1,2,3, H. Guimarães2, F. Dias de Castro1,2,3, M. J. Moreira1,2,3, J. Cotter1,2,3

1Hospital da Senhora da Oliveira, Gastroenterology, Guimarães, Portugal, 2Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga/Guimarães, Portugal, 3ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal

P143: Measuring the mediating effects of tofacitinib on health status in ulcerative colitis: data from the OCTAVE programme

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Dubinsky1, A. Bushmakin2, M. DiBonaventura3, J. Cappelleri4, L. Salese5, E. Maller5, A. Armuzzi*6

1Mount Sinai, New York, USA, 2Pfizer Inc., New York, USA, 3Pfizer Inc., Patient and Health Impact, New York, USA, 4Pfizer Inc., Groton, USA, 5Pfizer Inc., Collegeville, USA, 6Fondazione Policlinico Gemelli IRCCS – Università Cattolica del Sacro Cuore, Rome, Italy

P144: Correlation between clinical, endoscopic, histological activity scores in a cohort of patients with ulcerative colitis: a prospective study

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Neri*1, S. Romeo1, F. Zorzi1, E. De Cristofaro1, E. Calabrese1, E. Grasso1, G. Palmieri2, L. Biancone1

1University of Rome 'Tor Vergata', Gastroenterology, Rome, Italy, 2University or Rome 'Tor Vergata', Anatomopathology, Rome, Italy

P145: Telephone straight-to-test (tSTT) improves early diagnosis of inflammatory bowel disease (IBD)

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Htet*1, T. Mudege1, S. Hoque1

1Whipps Cross Hospital, Barts Health NHS Trust, London, UK

P146: Dysplasia Surveillance in inflammatory bowel disease—a cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Saraiva*1, I. Rosa1, J. Moleiro1, J. Pereira da Silva1, R. Fonseca1, A. Dias Pereira1

1Instituto Português de Oncologia de Lisboa Francisco Gentil, Gastroenterology, Lisbon, Portugal

P147: Thromboembolic complications in patients with Inflammatory bowel disease predict poor prognosis: a large North Indian cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Yadukrishna*1, V. Teja1, S. Kedia1, S. Jain1, P. Sahu1, S. Kumar1, G. Makharia1, V. Ahuja1

1All India Institute Of Medical Sciences, New Delhi, India

P148: Timing to surgery in symptomatic Crohn’s disease—patients perception

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Moratal1, M. Marti-Gallostra*1, F. Vallribera1, E. Epín1

1Hospital Vall d'Hebron, Colorectal surgery, Barcelona, Spain

P149: Searching for bile acid malabsorption using serum fibroblast growth factor 19 (FGF19) and faecal bile acids in patients with inflammatory bowel diseases, microscopic colitis and irritable bowel syndrome

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Lyutakov*1, R. Nakov1, V. Nakov1, B. Vladimirov1, A. Dimov2, B. Asenova3, M. Chetirska3, R. Vatcheva-Dobrevska3, P. Penchev1

1University Hospital ‘Tsaritsa Yoanna – ISUL’, Gastroenterology Clinic, Sofia, Bulgaria, 2University of National and World Economy, Department of Statistics and Econometrics, Sofia, Bulgaria, 3University Hospital ‘Tsaritsa Yoanna – ISUL’, Microbiology and Virology Department, Sofia, Bulgaria

P150: High adherence to surveillance guidelines in IBD results in low CRC and dysplasia rates, while rates of dysplasia and cancer are low before the suggested start of surveillance. Results from a tertiary IBD centre

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Singh1, A. Al Khoury2, Z. Kurti3, L. Gonczi*3, J. Reinglas2, C. Verdon2, R. Kohen2, T. Bessissow2, W. Afif2, G. Wild2, E. Seidman2, A. Bitton2, P. Lakatos2

1McGill University Health Center, Department of Medicine, Montreal, Canada, 2McGill University Health Center, Division of Gastroenterology, Montreal, Canada, 3Semmelweis University, First Department of Internal Medicine, Budapest, Hungary

P151: Risk factors for first intestinal surgery in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Novacek*1, W. Reinisch1, S. Reinisch1, C. Primas1, W. Eigner1, H. Vogelsang1, C. Dejaco1, L. Kazemi-Shirazi1, M. Niapir1, P. Mekhail1, N. Pedarnig2, H. Angermann2, T. Waldhör3

1Medical University of Vienna, Department of Internal Medicine III, Vienna, Austria, 2Unidata Geodesign, Vienna, Austria, 3Medical University of Vienna, Department of Epidemiology, Center of Public Health, Vienna, Austria

P152: Fatty liver disease in IBD patients as a part of extraintestinal manifestations

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Atanassova*1, A. Georgieva2

1Medical University Varna, Clinic of Hepatogastroenterology, St. Marina University Hospital, Varna, Bulgaria, 2Medical University Varna, Clinic of Hepatogastroenterology, St. Marina University Hospital, Vаrna, Bulgaria

P153: Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Ricken1, M. Schneider*1, F. Bantleon1, S. Velayutham1, D. Trapani1, J. Afonso2, F. Magro2, A. Abel1

1BÜHLMANN Laboratories AG, Schoenenbuch, Switzerland, 2Faculty of Medicine, University of Porto, Department of Biomedicine, Unit of Pharmacology and Therapeutics, Porto, Portugal

P154: Development of a novel ultrasound based score for assessing disease activity in ulcerative colitis: preliminary results

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Kakkadasam Ramaswamy*1, A. Yelsangikar1, K. V. Nagarajan1, A. Nagar1, N. Bhat1

1Aster CMI Hospital, Department of Gastroenterology, Liver Diseases and Clinical Nutrition, Bangalore, India

P155: Adherence to quality indicators among patients with inflammatory bowel disease: an international comparative analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Weizman*1, S. Coenen2, N. Afzal1, G. Nguyen1, G. Van Assche2

1Mount Sinai Hospital, Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Canada, 2Division of Gastroenterology and Hepatology, University of Leuven, Leuven, Belgium

P156: Long-term outcomes of steroid-responsive and non-responsive patients with acute severe ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Bernardo*1, S. Fernandes1, J. Estorninho2, J. Cortez Pinto3, I. Mocanu4, J. Sabino4, I. Rosa3, F. Portela2, L. Correia1

1Hospital Santa Maria, CHLN, Gastrenterology, Lisbon, Portugal, 2Centro Hospitalar Universitário de Coimbra, Gastrenterology, Coimbra, Portugal, 3Instituto Português de Oncologia Francisco Gentil, Lisboa, Gastrenterology, Lisbon, Portugal, 4Hospital Garcia de Orta, Almada, Gastrenterology, Almada, Portugal

P157: Assessment of sexual function among perianal Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Elleuch1, A. Nakhli2, M. Sabbah2, H. Jlassi2, D. Trad2, N. Bibani2, H. Elloumi2, A. Ouakaa*2, D. Gargouri2

1Medecine Faculty of Tunis, Tunis, Tunisia, 2Medecine Faculty of Tunis, Gastroenterology department of Habib Thameur Hospital (Tunisia), Tunis, Tunisia

P158: Comparison of three endoscopic scores for prediction of relapse risk in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Horita*1, E. Saito1, M. Motobayashi1, K. Suzuki1, K. Takenaka1, H. Shimizu1, T. Fujii1, M. Nagahori1, K. Ohtsuka1, M. Watanabe1

1Tokyo Medical and Dental University, Gastroenterology and Hepatology, Tokyo, Japan

P159: The creatinine / cystatin C ratio is a surrogate marker of low skeletal muscle mass in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. Ohta*1, T. Nakagawa1, Y. Imai1, T. Ooike1, Y. Yokoyama1, N. Akizue1, K. Ishikawa1, T. Taida1, K. Okimoto1, K. Saito1, D. Maruoka1, T. Matsumura1, M. Arai2, N. Kato1

1Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan, 2 Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan